• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型γ-突触核蛋白特异性单克隆抗体在评估结直肠癌患者血清和癌组织中其水平的应用。

Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.

作者信息

Liu Caiyun, Guo Jianping, Qu Like, Bing Dong, Meng Lin, Wu Jian, Shou Chengchao

机构信息

The Key Laboratory of Ministry of Education for Cancer Research and its Application, Department of Biochemistry & Molecular Biology, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Haidian District, Beijing 100036, China.

出版信息

Cancer Lett. 2008 Sep 28;269(1):148-58. doi: 10.1016/j.canlet.2008.04.037. Epub 2008 Jun 30.

DOI:10.1016/j.canlet.2008.04.037
PMID:18586385
Abstract

Overexpressions of synuclein-gamma (SNCG) in different cancers display stage-specific patterns. At present, appropriate anti-SNCG monoclonal antibodies (mAbs) with high specificity and affinity are unavailable for different immunoassays in clinical applications. In this study, we generated 10 mAbs against endogenous SNCG and evaluated SNCG levels in several colorectal cancer cell lines, serum samples and tumor tissues from colorectal cancer (CRC) patients. Elevated SNCG levels in cancer cell lines evaluated by a novel sandwich ELISA were consistent with data obtained from Western blot. Secreted SNCG protein levels in sera from CRC patients could be detected by the sandwich ELISA and were further confirmed by Western blot analysis following SNCG enrichment. Immunohistochemical results showed that SNCG was highly expressed in tumor cells of CRC patients, but was undetectable in the adjacent normal epithelium. Taken together, these novel anti-SNCG mAbs specifically recognized endogenous SNCG and were suitable for measuring SNCG levels in cell lysates, human serum samples, and tumor tissues. Elevated serum SNCG and overexpressed SNCG in tumor tissue from CRC patients suggest SNCG is a potential biomarker for CRC.

摘要

γ-突触核蛋白(SNCG)在不同癌症中的过表达呈现出阶段特异性模式。目前,在临床应用的不同免疫分析中,尚无具有高特异性和亲和力的合适抗SNCG单克隆抗体(mAb)。在本研究中,我们制备了10种针对内源性SNCG的mAb,并评估了几种结肠癌细胞系、血清样本以及来自结直肠癌(CRC)患者的肿瘤组织中的SNCG水平。通过一种新型夹心ELISA评估的癌细胞系中升高的SNCG水平与蛋白质印迹法获得的数据一致。夹心ELISA可检测CRC患者血清中分泌的SNCG蛋白水平,并且在SNCG富集后通过蛋白质印迹分析进一步得到证实。免疫组织化学结果显示,SNCG在CRC患者的肿瘤细胞中高表达,但在相邻正常上皮中未检测到。综上所述,这些新型抗SNCG mAb可特异性识别内源性SNCG,适用于测量细胞裂解物、人血清样本和肿瘤组织中的SNCG水平。CRC患者血清SNCG升高以及肿瘤组织中SNCG过表达表明SNCG是CRC的潜在生物标志物。

相似文献

1
Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.新型γ-突触核蛋白特异性单克隆抗体在评估结直肠癌患者血清和癌组织中其水平的应用。
Cancer Lett. 2008 Sep 28;269(1):148-58. doi: 10.1016/j.canlet.2008.04.037. Epub 2008 Jun 30.
2
Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.结合临床验证的肿瘤细胞-微环境相互作用模型揭示CCL2和SNCG是结直肠癌肝转移的两个预测指标。
Clin Cancer Res. 2009 Sep 1;15(17):5485-93. doi: 10.1158/1078-0432.CCR-08-2491. Epub 2009 Aug 25.
3
Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers.作为多种人类癌症转移分子指标的突触核蛋白γ基因表观遗传调控缺失
Cancer Res. 2005 Sep 1;65(17):7635-43. doi: 10.1158/0008-5472.CAN-05-1089.
4
Expression of alpha-, beta- and gamma-synuclein in colorectal cancer, and potential clinical significance in progression of the disease.α-、β-和 γ-突触核蛋白在结直肠癌中的表达及其在疾病进展中的潜在临床意义。
Oncol Rep. 2010 Feb;23(2):429-36.
5
Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.通过表观遗传改变导致肝细胞癌中γ-突触核蛋白基因异常激活。
Int J Oncol. 2006 May;28(5):1081-8.
6
Stage-specific expression of breast cancer-specific gene gamma-synuclein.乳腺癌特异性基因γ-突触核蛋白的阶段特异性表达。
Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):920-5.
7
Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.神经元蛋白γ-突触核蛋白可预测乳腺癌的不良临床结局。
Int J Cancer. 2007 Sep 15;121(6):1296-305. doi: 10.1002/ijc.22763.
8
Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells.突触核蛋白γ抑制有丝分裂检查点功能并促进乳腺癌细胞的染色体不稳定。
Breast Cancer Res Treat. 2005 Nov;94(1):25-35. doi: 10.1007/s10549-005-6938-0.
9
Identification of Cystatin SN as a novel tumor marker for colorectal cancer.鉴定胱抑素SN作为结直肠癌的一种新型肿瘤标志物。
Int J Oncol. 2009 Jul;35(1):33-40.
10
The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.CpG岛低甲基化和神经元蛋白突触核蛋白γ(SNCG)异常表达在卵巢癌中的作用。
Neuro Endocrinol Lett. 2006 Jun;27(3):381-6.

引用本文的文献

1
Upregulation of Synuclein- and Snai1 Contributes to Poor Clinical Prognosis in Oral Squamous Cell Carcinoma Patients.Synuclein 和 Snai1 的上调与口腔鳞状细胞癌患者的不良临床预后相关。
Biomed Res Int. 2022 Apr 7;2022:6534626. doi: 10.1155/2022/6534626. eCollection 2022.
2
Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.细胞外γ-突触核蛋白通过激活β1 整合素-黏着斑激酶信号通路,增加基质金属蛋白酶-24、-2 蛋白的分泌,促进肿瘤细胞迁移。
J Exp Clin Cancer Res. 2018 Jun 15;37(1):117. doi: 10.1186/s13046-018-0783-6.
3
Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of γ-synuclein in hepatocellular carcinoma cells.
长链非编码RNA AK058003作为miR-15a的前体,与HuR相互作用以抑制肝癌细胞中γ-突触核蛋白的表达。
Oncotarget. 2017 Feb 7;8(6):9451-9465. doi: 10.18632/oncotarget.14276.
4
Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.子宫浆液性癌中的γ-突触核蛋白影响生存:一项NRG肿瘤学/妇科肿瘤学组的研究。
Cancer. 2017 Apr 1;123(7):1144-1155. doi: 10.1002/cncr.30477. Epub 2016 Dec 7.
5
Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease.卵巢癌中突触核蛋白γ(SNCG)的表达与高危临床病理疾病相关。
J Ovarian Res. 2016 Nov 3;9(1):75. doi: 10.1186/s13048-016-0281-4.
6
Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer.尿γ-突触核蛋白作为膀胱癌诊断的生物标志物。
Oncotarget. 2016 Jul 12;7(28):43432-43441. doi: 10.18632/oncotarget.9468.
7
Identification of γ-synuclein as a stage-specific marker in bladder cancer by immunohistochemistry.免疫组织化学鉴定 γ-突触核蛋白作为膀胱癌的阶段特异性标志物。
Med Sci Monit. 2014 Dec 5;20:2550-5. doi: 10.12659/MSM.892927.
8
siRNA-Mediated Suppression of Synuclein γ Inhibits MDA-MB-231 Cell Migration and Proliferation by Downregulating the Phosphorylation of AKT and ERK.siRNA 介导的γ-突触核蛋白抑制通过下调 AKT 和 ERK 的磷酸化抑制 MDA-MB-231 细胞的迁移和增殖。
J Breast Cancer. 2014 Sep;17(3):200-6. doi: 10.4048/jbc.2014.17.3.200. Epub 2014 Sep 30.
9
Synuclein gamma protects HER2 and renders resistance to Hsp90 disruption.γ 突触核蛋白保护 HER2 并使其对热休克蛋白 90 破坏产生抗性。
Mol Oncol. 2014 Dec;8(8):1521-31. doi: 10.1016/j.molonc.2014.05.011. Epub 2014 Jun 14.
10
Synuclein γ protects Akt and mTOR and renders tumor resistance to Hsp90 disruption.突触核蛋白γ可保护Akt和mTOR,并使肿瘤对Hsp90破坏产生抗性。
Oncogene. 2015 Apr 30;34(18):2398-405. doi: 10.1038/onc.2014.126. Epub 2014 Jun 23.